AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30993499 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Session Intervention (SSI) teaching growth mindset
Number of subjects: 96
Study 29444682 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG subclass deficiency (IgG1 < 2.8 g/L; IgG2 < 1.15 g/L) in MACRO cohort
Number of subjects: 1629
Study 29444682 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG subclass deficiency (IgG1 < 2.8 g/L; IgG2 < 1.15 g/L) in STATCOPE cohort
Number of subjects: 1629
Study 29444682 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG3 and IgG4 levels
Number of subjects: 1629
Study 26808817 — intervention group
Group type: EXPERIMENTAL
Intervention: SUMMIT
Number of subjects: 232
Study 26808817 — intervention group
Group type: EXPERIMENTAL
Intervention: SUMMIT-PERSON
Number of subjects: 232
Study 26808817 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 232
Study 25531993 — intervention group
Group type: EXPERIMENTAL
Intervention: RMB (Rabeprazole/Rifabutin/Minocycline/Bismuth sub‐citrate) for 10 days
Number of subjects: 54
Study 25531993 — intervention group
Group type: COMPARATOR
Intervention: MTB (Rabeprazole/Tinidazole/Minocycline/Bismuth sub‐citrate) for 10 days
Number of subjects: 54
Study 22983782 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical muscle stimulation‐assisted supine cycling on one leg while the other leg undergoes cycling alone
Number of subjects: 80
Study 22983782 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study 19963333 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg once weekly for 8 weeks
Number of subjects: 10
Study 19963333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 19016075 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Aspart (IAsp) 0.06 IU/kg BW
Number of subjects: 20
Study 19016075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16129614 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tube thoracostomy and streptokinase instillation (group B)
Number of subjects: 127
Study 16129614 — intervention group
Group type: COMPARATOR
Intervention: Sole tube thoracostomy (group A)
Number of subjects: 127
Study 12145004 — intervention group
Group type: EXPERIMENTAL
Intervention: SE-enriched spread (18.2 +/- 1.5 g SE spread/d, corresponding to 1.60 +/- 0.13 g SEs)
Number of subjects: 38
Study 12145004 — intervention group
Group type: EXPERIMENTAL
Intervention: SE-enriched spread
Number of subjects: 38
Study 12145004 — intervention group
Group type: COMPARATOR
Intervention: Control spread
Number of subjects: 38
Study 10456525 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg/day subcutaneous recombinant human growth hormone (rhGH)
Number of subjects: 94
Study 10456525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 7541782 — intervention group
Group type: EXPERIMENTAL
Intervention: Mapping-enhanced counseling
Number of subjects: 331
Study 7541782 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 331
Study 2193276 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring contraction rate at home (threshold of at least four contractions per hour)
Number of subjects: 105
Study 526527 — intervention group
Group type: EXPERIMENTAL
Intervention: Different sets of treatments
Number of subjects: 0
Study 526527 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased sample size
Number of subjects: 0
Study 526527 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted randomization
Number of subjects: 0
Study 31411695 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 54
Study 31411695 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 54
Study 30253697 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris (3 times daily for 3 months)
Number of subjects: 70
Study 30253697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 29249805 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS + ADP
Number of subjects: 281
Study 29249805 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 281
Study 29249805 — intervention group
Group type: COMPARATOR
Intervention: ADP
Number of subjects: 281
Study 26934401 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 34
Study 26934401 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (Control)
Number of subjects: 34
Study 25132459 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg i.v. paracetamol
Number of subjects: 120
Study 25132459 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 120
Study 22935339 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed snack regimen (2 snacks, fed 4 hours apart)
Number of subjects: 10
Study 22935339 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable snack regimen (2 snacks based on body surface area, fed 4 hours apart)
Number of subjects: 10
Study 22935339 — intervention group
Group type: COMPARATOR
Intervention: Both fixed and variable snacks
Number of subjects: 10
Study 19683638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control (target systolic blood pressure < 130 mm Hg)
Number of subjects: 1111
Study 19683638 — intervention group
Group type: COMPARATOR
Intervention: Usual control (target systolic blood pressure < 140 mm Hg)
Number of subjects: 1111
Study 19683638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control
Number of subjects: 1111
Study 19683638 — intervention group
Group type: COMPARATOR
Intervention: Usual control
Number of subjects: 1111
Study 17295580 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 75
Study 17295580 — intervention group
Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 75
Study 17295580 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 75
Study 17295580 — intervention group
Group type: COMPARATOR
Intervention: Active medication (Sertraline)
Number of subjects: 75
Study 15895833 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate injections (1.0 mol/L)
Number of subjects: 26
Study 15895833 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injections (0.165 mol/L)
Number of subjects: 26
Study 12795239 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg i.v. bolus
Number of subjects: 28
Study 12795239 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg i.m. injection
Number of subjects: 28
Study 12795239 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg i.v. infusion
Number of subjects: 28
Study 9578931 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ipratropium bromide (0.06% two sprays per nostril) and oxymetazoline (0.05% two sprays per nostril)
Number of subjects: 109
Study 9578931 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline alone
Number of subjects: 109
Study 9578931 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 109
Study 9578931 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ipratropium bromide and oxymetazoline
Number of subjects: 109
Study 9578931 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 109
Study 7643883 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 4098
Study 2794470 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 17
Study 2794470 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (HP)
Number of subjects: 17
Study 385100 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine, 1.6 g daily for six months
Number of subjects: 20
Study 385100 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo for six months
Number of subjects: 20
Study 29697291 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (vild) plus standard medical treatment
Number of subjects: 60
Study 29697291 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 60
Study 27527256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin for four months
Number of subjects: 31
Study 27527256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 24885124 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated FiO2-SpO2 control system with a control range of 87-93% SpO2
Number of subjects: 21
Study 24885124 — intervention group
Group type: COMPARATOR
Intervention: Automated FiO2-SpO2 control system with a control range of 90-93% SpO2
Number of subjects: 21
Study 22879314 — intervention group
Group type: EXPERIMENTAL
Intervention: basic fibroblast growth factor (bFGF) treatment
Number of subjects: 20
Study 22879314 — intervention group
Group type: COMPARATOR
Intervention: impregnated gauze treatment (control)
Number of subjects: 20
Study 20174819 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-fixating Parietene progrip mesh (group A)
Number of subjects: 50
Study 20174819 — intervention group
Group type: COMPARATOR
Intervention: Traditional Lichtenstein repair (group B)
Number of subjects: 50
Study 18362422 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin (1 or 2 mg/day)
Number of subjects: 30
Study 18362422 — intervention group
Group type: COMPARATOR
Intervention: No statin therapy
Number of subjects: 30
Study 15383370 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-6 infusion for 3 hours
Number of subjects: 2
Study 15383370 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-6 infusion
Number of subjects: 2
Study 15383370 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 treatment alone
Number of subjects: 2
Study 15383370 — intervention group
Group type: COMPARATOR
Intervention: IL-6 plus dexamethasone and GH
Number of subjects: 2
Study 15383370 — intervention group
Group type: COMPARATOR
Intervention: IL-6 and AICAR
Number of subjects: 2
Study 12433762 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg daily
Number of subjects: 1568
Study 12433762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1568
Study 11221128 — intervention group
Group type: EXPERIMENTAL
Intervention: Information programme and distribution of female and male condoms at intervention sites
Number of subjects: 1929
Study 11221128 — intervention group
Group type: COMPARATOR
Intervention: Male condoms only and similar information about them at control sites
Number of subjects: 1929
Study 8997654 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 1.5% SLS and 0.3% triclosan
Number of subjects: 0
Study 8997654 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 3% SLS and 0.3% triclosan
Number of subjects: 0
Study 8997654 — intervention group
Group type: COMPARATOR
Intervention: Positive control toothpaste containing 1.5% SLS without triclosan
Number of subjects: 0
Study 1984942 — intervention group
Group type: EXPERIMENTAL
Intervention: TF‐IMT (PR + IMT)
Number of subjects: 40
Study 1984942 — intervention group
Group type: COMPARATOR
Intervention: PR (Control)
Number of subjects: 40
Study 6624851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral habilitation program (sensorimotor facilitation procedures)
Number of subjects: 4
Study 30615947 — intervention group
Group type: EXPERIMENTAL
Intervention: ADF and exercise (E‐ADF)
Number of subjects: 112
Study 30615947 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 112
Study 30615947 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 112
Study 30615947 — intervention group
Group type: EXPERIMENTAL
Intervention: ADF
Number of subjects: 112
Study 29321340 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC/2.4 method
Number of subjects: 390
Study 29321340 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC/3 method
Number of subjects: 390
Study 29321340 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC/2 method
Number of subjects: 390
Study 29321340 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiautomatic segmentation
Number of subjects: 390
Study 27116282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathogen-reduced whole blood (treated)
Number of subjects: 226
Study 27116282 — intervention group
Group type: COMPARATOR
Intervention: Standard untreated whole blood (untreated)
Number of subjects: 226
Study 25588906 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D spiral sequence (GE)
Number of subjects: 22
Study 25588906 — intervention group
Group type: COMPARATOR
Intervention: 2D EPI sequence (Philips)
Number of subjects: 22
Study 23116500 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic miniscrew implants
Number of subjects: 2281
Study 20022431 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological analgesia with low-cost VR system (eMagin Z800 3DVisor)
Number of subjects: 11
Study 20022431 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological analgesia without VR system
Number of subjects: 11
Study 18532969 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerclage suture
Number of subjects: 78
Study 18532969 — intervention group
Group type: COMPARATOR
Intervention: Cautery
Number of subjects: 78
Study 16491691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cup-stacking instructional unit (3 weeks)
Number of subjects: 69
Study 16491691 — intervention group
Group type: COMPARATOR
Intervention: Standard physical education curriculum
Number of subjects: 69
Study 11815967 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose-rate (HDR) intracavitary radiation therapy
Number of subjects: 132
Study 11815967 — intervention group
Group type: COMPARATOR
Intervention: Low-dose-rate (LDR) intracavitary radiation therapy
Number of subjects: 132
Study 10431991 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic compression
Number of subjects: 562
Study 10431991 — intervention group
Group type: EXPERIMENTAL
Intervention: Saphenous ligation
Number of subjects: 562
Study 10431991 — intervention group
Group type: EXPERIMENTAL
Intervention: Stripping of the affected veins
Number of subjects: 562
Study 10431991 — intervention group
Group type: COMPARATOR
Intervention: Compression alone
Number of subjects: 562
Study 10431991 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 562
Study 10431991 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulant (OC) treatment
Number of subjects: 562
Study 10431991 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous heparin (LDSH)
Number of subjects: 562
Study 7595068 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet high in stearic acid (C18)
Number of subjects: 27
Study 7595068 — intervention group
Group type: COMPARATOR
Intervention: Diet high in palmitic acid (C16)
Number of subjects: 27
Study 7595068 — intervention group
Group type: COMPARATOR
Intervention: Diet high in myristic+lauric acid (C12+C14)
Number of subjects: 27
Study 2209889 — intervention group
Group type: EXPERIMENTAL
Intervention: Dummy embryo transfer (ET)
Number of subjects: 335
Study 2209889 — intervention group
Group type: COMPARATOR
Intervention: No dummy embryo transfer (Control)
Number of subjects: 335
Study 7051739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolfenamic acid
Number of subjects: 31
Study 7051739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 31102063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 431
Study 31102063 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + Fluoxetine (COMB)
Number of subjects: 431
Study 31102063 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy for Adolescents (IPT-A)
Number of subjects: 431
Study 28850367 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg mavatrep
Number of subjects: 33
Study 28850367 — intervention group
Group type: EXPERIMENTAL
Intervention: 500mg naproxen
Number of subjects: 33
Study 28850367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 26184461 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone long acting injection
Number of subjects: 22
Study 26184461 — intervention group
Group type: EXPERIMENTAL
Intervention: flupenthixol decanoate
Number of subjects: 22
Study 26184461 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched healthy volunteers)
Number of subjects: 22
Study 24819857 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol‐dorzolamide fixed‐combination drops twice daily when IOP exceeded 10 mmHg
Number of subjects: 94
Study 24819857 — intervention group
Group type: COMPARATOR
Intervention: Conventional stepwise treatment when IOP exceeded target pressure
Number of subjects: 94
Study 21978930 — intervention group
Group type: EXPERIMENTAL
Intervention: Support-based smoking cessation intervention
Number of subjects: 0
Study 19296033 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-adult-led intervention (four-hour group session)
Number of subjects: 530
Study 19296033 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 530
Study 19296033 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-adult-led intervention
Number of subjects: 530
Study 21357960 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourier transform infrared spectroscopy (FTIR) analysis of torn rotator cuff tendons
Number of subjects: 81
Study 21357960 — intervention group
Group type: COMPARATOR
Intervention: Fourier transform infrared spectroscopy (FTIR) analysis of uninjured control tendons
Number of subjects: 81
Study 16136765 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib (120 mg)
Number of subjects: 58
Study 16136765 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (200 mg)
Number of subjects: 58
Study 12271371 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia (oxybutynin 0.4% eye drops and cocaine hydrochloride 10% eye drops)
Number of subjects: 20
Study 12271371 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (5 ml mepivacaine 2% injected into the retrobulbar space)
Number of subjects: 20
Study 10397541 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized, unrestricted antiretroviral therapy
Number of subjects: 173
Study 8642546 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol 6 g daily for 5 days before the 5th or 6th ECT
Number of subjects: 0
Study 2197098 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 8
Study 2197098 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril 40 mg
Number of subjects: 8
Study 2197098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7389356 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol cypionate
Number of subjects: 29
Study 7389356 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate
Number of subjects: 29
Study 7389356 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol benzoate
Number of subjects: 29
Study 7389356 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 29
Study 28691541 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazelnuts
Number of subjects: 61
Study 28691541 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazelnut-Cocoa
Number of subjects: 61
Study 28691541 — intervention group
Group type: EXPERIMENTAL
Intervention: Peeled Hazelnut Snack
Number of subjects: 61
Study 28691541 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazelnut-Cocoa Integration
Number of subjects: 61
Study 27648000 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-DM group
Number of subjects: 80
Study 27648000 — intervention group
Group type: COMPARATOR
Intervention: DM group
Number of subjects: 80
Study 27648000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 23278375 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading implants (test)
Number of subjects: 12
Study 23278375 — intervention group
Group type: COMPARATOR
Intervention: Early loaded implants (control)
Number of subjects: 12
Study 22607887 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive therapy
Number of subjects: 246
Study 22607887 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 246
Study 20367770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 30 mg
Number of subjects: 1162
Study 20367770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 1162
Study 20367770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine (30 mg or 60 mg)
Number of subjects: 1162
Study 20367770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1162
Study 18195564 — intervention group
Group type: EXPERIMENTAL
Intervention: Trizivir plus efavirenz
Number of subjects: 209
Study 18195564 — intervention group
Group type: EXPERIMENTAL
Intervention: Trizivir plus lopinavir/ritonavir
Number of subjects: 209
Study 18195564 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 209
Study 15516345 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 41
Study 15516345 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 41
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: NDS (fresh gas flow of 1 litre/min without additional dead-space volumes)
Number of subjects: 45
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: DS + 1.0 (fresh gas flow of 1 litre/min with additional dead-space volumes)
Number of subjects: 45
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: DS + 0.5 (fresh gas flow of 0.5 litre/min with additional dead-space volumes)
Number of subjects: 45
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: DS + 1.0
Number of subjects: 45
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: DS + 0.5
Number of subjects: 45
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: DS groups
Number of subjects: 45
Study 12027842 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study 10444053 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic RGP bitoric lens
Number of subjects: 0
Study 10444053 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic PMMA spherical lens
Number of subjects: 0
Study 7851590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal transfer of cryopreserved embryos
Number of subjects: 40